NCT02730702View on ClinicalTrials.gov

Colon Cancer Risk-stratification Via Optical Analysis of Rectal Ultrastructure

UnknownOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

September 30, 2020

Study Completion Date

September 30, 2020

Conditions
Colon Cancer
Interventions
DEVICE

LEBS - Low coherence enhanced backscattering

Unprepped patients will have the LEBS probe brought into contact with the rectal mucosa, upon which 10 random readings will be obtained.

Trial Locations (1)

02118

Boston Medical Center, Boston

Sponsors
All Listed Sponsors
lead

American BioOptics, LLC

INDUSTRY

NCT02730702 - Colon Cancer Risk-stratification Via Optical Analysis of Rectal Ultrastructure | Biotech Hunter | Biotech Hunter